+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer



Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer



Journal of Oncology 2011: 620523



Epithelial ovarian cancer stem cells (EOC stem cells) have been associated with recurrence and chemoresistance. CD44 and CK18 are highly expressed in cancer stem cells and function as tools for their identification and characterization. We investigated the association between the number of CD44+ EOC stem cells in ovarian cancer tumors and progression-free survival. EOC stem cells exist as clusters located close to the stroma forming the cancer stem cell "niche". 17.1% of the samples reveled high number of CD44+ EOC stem cells (>20% positive cells). In addition, the number of CD44+ EOC stem cells was significantly higher in patients with early-stage ovarian cancer (FIGO I/II), and it was associated with shorter progression-free survival (P = 0.026). This study suggests that quantification of the number of EOC stem cells in the tumor can be used as a predictor of disease and could be applied for treatment selection in early-stage ovarian cancer.

(PDF emailed within 0-6 h: $19.90)

Accession: 055157594

Download citation: RISBibTeXText

PMID: 21904548

DOI: 10.1155/2011/620523


Related references

Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer. Neoplasia 12(4): 317-325, 2010

Predictive factors of recurrence in patients with early-stage epithelial ovarian cancer. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 2019, 2019

The omentum and omentectomy in epithelial ovarian cancer: a reappraisal: part II--The role of omentectomy in the staging and treatment of apparent early stage epithelial ovarian cancer. Gynecologic Oncology 131(3): 784-790, 2014

High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer. Reproductive Sciences 20(5): 605-615, 2013

Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecologic Oncology 116(3): 307-311, 2010

The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases. Disease Markers 2014: 238197, 2015

Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer. European Journal of Gynaecological Oncology 30(2): 208-210, 2009

Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study. Gynecologic Oncology 121(1): 94-99, 2011

Comparison of advanced stage mucinous epithelial ovarian cancer and serous epithelial ovarian cancer with regard to chemosensitivity and survival outcome: a matched case-control study. Journal of Gynecologic Oncology 24(2): 160-166, 2013

ADVANCED STAGE OF EPITHELIAL OVARIAN CANCER (II-IV FIGO STAGE). THE ROLE OF LYMPH NODE DISSECTION: IGCS-0019 Ovarian Cancer. International Journal of Gynecological Cancer 25 Suppl 1: 53, 2015

Impact of intraoperative rupture of the ovarian capsule on prognosis in patients with early-stage epithelial ovarian cancer: a meta-analysis. European Journal of Surgical Oncology 39(3): 279-289, 2013

Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer. Journal of Gynecologic Oncology 19(4): 223-228, 2009

Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids. Oncotarget 7(52): 86374-86387, 2016

DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells. Gynecologic Oncology 82(2): 299-304, 2001

In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer. Gynecologic Oncology 98(2): 182-192, 2005